SlideShare a Scribd company logo
1 of 32
VALIDATION
MEHAK AGGARWAL
M.PHARM (PHARMACEUTICS)
CONTENT
Introduction
Objectives of Validation
Scope & Merits of Validation
Validation Master Plan
Calibration Master Plan
ICH and WHO guidelines for Calibration & Validation of equipment
References
4/6/2022
MEHAK AGGARWAL 2
INTRODUCTION
•As per FDA Validation, It is defined as “ establishing a Documented evidence, which provides a
high degree of assurance that a specific process will consistently produce a product meeting its
pre-determined specifications and quality attributes”.
•As per WHO, Validation means providing documented evidence that any procedure, process,
activity or system actually leads to the expected results.
•According to European commission, validation is “Action providing in accordance with the
principles of GMP, that any procedure, process, equipment, material, activity or system actually
lead to the expected results”.
4/6/2022
MEHAK AGGARWAL 3
OBJECTIVES
•To reach risk of regulatory non-compliance.
•Reduction of time to the market for the new products.
•Eliminates the scrap and reduces the defect cost.
•To reduce chances of product re-call from market.
•The final release of product batch would be expedited.
•It requires less in-process control and end process testing.
•Parametric release of batch can be achieved in validation.
4/6/2022
MEHAK AGGARWAL 4
SCOPE OF VALIDATION
•Pharmaceutical validation is a vast area of work and it practically courses every aspect of pharmaceutical
processing activities, hence defining scope of validation becomes a really difficult task. However, a
systematic look at the pharmaceutical operations will point out at least the following areas for
pharmaceutical validation:
Analytical
Facilities
Manufacturing operations
Product design
Cleaning
4/6/2022
MEHAK AGGARWAL 5
MERITS OF VALIDATION
•Knowledge of the process increases during the validation process.
•Consistency of the process is ensured.
•It decrease the risk of the manufacturing problems.
•Ensures the fluency of the production.
•Decrease the expenses.
•Decrease the risk of failing in GMP.
4/6/2022
MEHAK AGGARWAL 6
VALIDATION MASTER PLAN
(VMP)
•A validation master plan(VMP) is a comprehensive document describing the
applicable validation requirement for the facility, and providing a plan for the
meeting those requirements.
4/6/2022
MEHAK AGGARWAL 7
Scope of VMP
•VMP includes all relevant expects relating to the production of pharmaceuticals in the
production facility. The principle of validation, the organization of qualification and equipment
are also described.
•All facilities used in various production areas, storage, services and the rooms for staff.
In short, it is a documented evidence that provides a high degree of Assurance that a specific
process will consistently produce a product that makes its predetermined specifications and
quality attributes.
4/6/2022
MEHAK AGGARWAL 8
Why to perform VMP?
•VMP is not a requirement of FDA, but it has become almost an industry standard.
•It is important to include such a document, as it sets the overall goals and limits that will be followed
during validation and can be referred to throughout the project.
•As a reference document, the plan permits the reviewer immediately to understand the scope of the
validation and avoid misconceptions.
•The validation plan is thus used to set the limits of validation, to define the scope of the project, the
systems included and not included in the qualification and what the project will attempt to prove.
4/6/2022
MEHAK AGGARWAL 9
Members of VMP
•Validation manager, QA department
• Member from production
•Member engineering
•Member from calibration lab
•Member from QC lab
•Member from maintenance
•Member from HVAC department
•Member from product development lab
4/6/2022
MEHAK AGGARWAL 10
Qualification
•Qualification must be in accordance with the job requirement in combination with experience.
•The resumes of validation team members are presented in a separate folder, including contract help.
4/6/2022
MEHAK AGGARWAL 11
Content of VMP
1. Introduction
•Introduction to validation process and facility.
•Includes- description of facility, premises, equipment, purpose, intension and scope of validation.
2. Methodology
•It addresses pre-determined requirements by identifying standard that are to be applied to facility.
•These are then used in development of the acceptance criteria that are used to judge the validation.
•It involves planning, execution of documents, reports,
Standards involve three elements-
a) Regulatory and guidance document
b) National standard
c) Company standards
4/6/2022
MEHAK AGGARWAL 12
3. Qualification
•This section encompasses all aspects of design, installation and procurement, installation and commissioning process.
4. Personnel
•VMP should lay down the qualification requirements.
•It must address the aspects like experience of personnel, in-house training reports etc.
•Documenting the training is essential and is a requisite of the GMPs.
5. Schedule
•Work program is essential and should be prepared at an early stage. A good plan will contain all necessary features which
are to be considered during execution of a plan and determine control of project.
•It ensures that all personnel involved in VMP are not only aware of engineering targets but also validation targets.
4/6/2022
MEHAK AGGARWAL 13
6. Preventive maintenance
•It is responsibility of site maintenance and operation department.
•This activity should be performed during the design phase and that documentation required should
be, included in the requisition.
7. Procedures
•These cover engineering standards used in project design, through to commissioning phases and the
facilities standard procedures(SOPs).
8. Change control
•Requirements for a set of procedures for change control that cover:
oproject through design, construction and commissioning
o ongoing change that will inevitably occur in both process, equipment and engineering aspects.
4/6/2022
MEHAK AGGARWAL 14
9. Documentation
•Identify the documentation that should be produced for the processing like
oengineering drawing
oEquipment supplier drawing and documents
ofactory acceptance documents
oIQ document
oOQ document
oPQ document
10. Appendices
•Appendix is mostly used VMP to hold information of type of documents and formats that will be used
in execution stage.
4/6/2022
MEHAK AGGARWAL 15
CALIBRATION MASTER PLAN
CALIBRATION
•To maintain accuracy and precision of test equipment at all times.
•To ensure the highest level of confidence in all measurement that affect materials deposition decision
with unbroken chain of traceability to national standard.
•To determine whether equipment is still fit for its intended purpose.
•It is based on comparison of a primary standard or instrument of known accuracy with another
equipment (to be calibrated).
• It is used to detect, report or eliminate by adjustment of any variation in the accuracy of equipment
being calibrated.
4/6/2022
MEHAK AGGARWAL 16
CMP
•Assigning responsibilities for equipment users, equipment managers, quality assurance personnel and
calibration vendors to help and Shaw company-wide consistency and regulation of your processes.
•Approving calibration vendors such that they are in compliance with the guidelines of your quality
system.
•Identifying and labelling equipment.
•Processing investigations of out of tolerance conditions and other calibration related issues that may
necessitate corrective action.
•Controlling and storing records, including calibration certificates, status change forms and calibration
SOPs.
4/6/2022
MEHAK AGGARWAL 17
WHY CALIBRATE?
•Components age and equipment undergoes changes in temperature and humidity or sustains
mechanical stress and therefore their performance degrades. This is called drift. Then test results
become unreliable. While drift cannot be eliminated, it can be detected and either corrected or
compensated for through the process of calibration.
•Calibration:
ooptimizes resources
oensures consistence
oensure measurements
4/6/2022
MEHAK AGGARWAL 18
EQUIPMENT CLASSIFICATION
a) Critical equipment
•Direct measurement that affect the final product quality specification.
b) Non-critical equipment
•Indirect measurement that will not directly affect the final product quality.
•Shall be maintained based on company maintenance schedule.
PROCESS OF CALIBRATION
•Calibration process must be managed and executed in a professional manner. A particular place for all calibration
operations to take place and keeping all instruments for calibration.
•Separate room is preferred because
obetter environmental control
obetter protection against unauthorized handling or use of calibration instruments.
4/6/2022
MEHAK AGGARWAL 19
•Performance of all calibration operations is assigned as the clear responsibility of just one person.
•Calibration procedures, used for QC function are controlled by International standard ISO 9000. It
required that all persons using calibration equipment be adequately trained.
VERIFICATION
•Applicable to equipment that cannot be calibrated (adjustment, correlation, etc.).
•Verification against measurement standard with correlation factor documented.
•Actual reporting of result shall include the correlation factor-
correlation factor = -2ºC
measured value =24ºC
reported value = 24ºC-2ºC=22ºC
4/6/2022
MEHAK AGGARWAL 20
CALIBRATION RECORDS
CMP include the control of all critical measurement equipment that contain the following detail.
•Name
•Identification by model number and serial number
•Location
•Owner/responsible
•Calibration frequency
•Calibration due date
•Calibration certificate
•Calibration procedure
4/6/2022
MEHAK AGGARWAL 21
CALIBRATION CERTIFICATE
•Name and address of contracted calibration laboratory.
•Name and address of client.
•Description and identification of item calibrated.
•Environment conditions when calibration was made.
•Date of receipt of instrument, date of calibration and date of next calibration.
•Calibration method.
•Result of calibration.
•Signature and title of person responsible for the calibration.
•External calibration contract shall be awarded to accredited by Nation Institution.
4/6/2022
MEHAK AGGARWAL 22
ICH AND WHO GUIDELINES FOR CALIBRATION &
VALIDATION OF EQUIPMENT
ICH GUIDELINES FOR CALIBRATION OF EQUIPMENT
•Local identification by a unique identification number and involvement in master GMP instrument list
•Procedure for instrument history file.
•Approval by quality unit.
•Generation of procedure for verification and standardization of accuracy and reliability.
•For approval of procedure, it must contain steps and forms required for calibration.
•Involvement of calibration stickers and auxiliary stickers program.
•Procedure for tracking of Scheduled calibration activities.
•Procedure for notifying users of calibration due dates, overdue calibrations and out of tolerance findings.
4/6/2022
MEHAK AGGARWAL 23
•Review of all systems, calibration records and procedure by quality unit.
•Involvement of procedure for reporting any GMP critical instrument.
•Involvement of calibration forms which are developed to record the calibration results.
WHO GUIDELINES FOR CALIBRATION OF EQUIPMENT
•Regular calibration.
•Establishment of specific procedure of calibration for every equipment.
•Only authorized personnel should operate equipment.
•Availability of up-to-date instructions for calibration verification results must be recorded on a control chart.
•Unique identification of each item of equipment for calibration.
•Keeping of records of each item of equipment to perform calibration.
•Systematic verification of laboratory to prevent contamination.
•Establishment of maintenance procedure.
4/6/2022
MEHAK AGGARWAL 24
•Out of service equipment.
•Labelling of equipment.
•Verification of equipment function and calibration status.
EXAMPLE FOR CALIBRATION OF UV SPECTROPHOTOMETER
1. Control of wavelength
• Verify wavelength scale using absorption maxima of holmium per chlorate solution with the line of
hydrogen or deuterium discharge lamp or lines of mercury vapor arc.
•The permitted tolerance is +/-1 nm for the range 200 to 400nm.
2. Control of absorbance
•Check the absorbance using potassium dichromate solution UV at different wavelengths.
4/6/2022
MEHAK AGGARWAL 25
3. Limit of stray light
•Detected at a given wavelength with suitable filters or solutions; for ex. potassium chloride.
4. Resolution power
•Record the spectrum of a 0.02% v/v solution of toluene in hexane UV. Ratio of the absorbance is NLT
1.5 .
5. Spectral slit width
•Spectral slit width must be small compared with the half- width of the absorption band.
4/6/2022
MEHAK AGGARWAL 26
ICH GUIDELINES FOR VALIDATION OF EQUIPMENT
•1 meter distance from walls and other obstacles.
•Easy to operate, clean and maintainable.
•Working should be at proper commissioned position.
•Certification of equipment.
•Checking of overhead heights.
•Proper source of light.
•Drop down utility system.
•Design of equipment.
•Layout of equipment.
•Marking of pipelines as per their flow of direction.
4/6/2022
MEHAK AGGARWAL 27
•Sop the equipment.
•Tracing of equipment.
•Identification marking for equipment.
•Cleaning of equipment.
•Distinguishing of the equipment.
•Record of each processing.
WHO GUIDELINES FOR VALIDATION OF EQUIPMENT
•Equipment must be located, designed, constructed, adapted and maintained to suit the operation.
•Layout and design of equipment.
•Instalment of equipment.
•Production equipment.
4/6/2022
MEHAK AGGARWAL 28
•Labelling of fixed pipe work.
•Cleaning of equipment.
•Labelling of equipment.
•Establishment of written procedures for each operation.
•Record keeping.
EXAMPLE OF VALIDATION OF TABLET COMPRESSION MACHINE
1. Execution of Design
2. Qualification Execution of IQ, OQ and PQ
3. Procedure Followed for Performance Qualification
•The blend/dummy material was unloaded into the hoppers on the both sides and the compression
machine was operated at low speed (20RPM) as per operating instructions. Then the machine was set to
run for 20 minutes continuously after adjusting the following parameters-
4/6/2022
MEHAK AGGARWAL 29
oIndividual tablet weight variation
oWeight of 20 tablets
oHardness
oThickness
oDisintegration time
oFriability
•Repeat the procedure at both medium (40RPM) and high speed (60RPM) with same set of parameters.
•Checking of parameters at different speeds.
•Report the results.
•Sampling Plan
1. Collect 100 tablets for every 05 minutes.
2. Compression parameters checked at different speeds.
•Optimum results obtained at 40 rpm speed.
4/6/2022
MEHAK AGGARWAL 30
REFERENCES
•Potdar MA, “cGMP, current good manufacturing practises for pharmaceuticals”, 2nd reprint,
Pharmamed press, Hyderabad, p. 85,88-101,413-423.
•Joseph Busfield. cGMP, instrument and calibration. “Facilities, utilities and requirements, GXP, Ivt
network”. Feb 21,2007;5-7. Available from: https://www.ivtnetwork.com/article/cgmp-equipment-
instruments-and-calibration
•Guidelines : ICH. “ICH harmonization for better health”. Available from:
https://www.ich.org/page/ich-guidelines
•Essential medicines and health products information portal. “WHO expert committee on
specifications for pharmaceutical preparations”. World Health Organization.Technical report series
no. 902-36th report.2002.
4/6/2022
MEHAK AGGARWAL 31
4/6/2022
MEHAK AGGARWAL 32

More Related Content

What's hot

Six System Inspection Model.pptx
Six System Inspection Model.pptxSix System Inspection Model.pptx
Six System Inspection Model.pptxVIJAYAVICHARE
 
ICH Q8 GUIDELINES OF QUALITY BY DESIGN(PRODUCT DEVELOPEMENT)
ICH Q8 GUIDELINES OF QUALITY BY DESIGN(PRODUCT DEVELOPEMENT)ICH Q8 GUIDELINES OF QUALITY BY DESIGN(PRODUCT DEVELOPEMENT)
ICH Q8 GUIDELINES OF QUALITY BY DESIGN(PRODUCT DEVELOPEMENT)ROHIT
 
Study of consolidation parameters
Study of consolidation parametersStudy of consolidation parameters
Study of consolidation parametersMehak AggarwAl
 
Current Goods Manufacturing Practice & Industrial Management
Current Goods Manufacturing Practice & Industrial ManagementCurrent Goods Manufacturing Practice & Industrial Management
Current Goods Manufacturing Practice & Industrial ManagementLukman N Kerur
 
DIffusion, Dissolution and Pharmacokinetic Parameters.pptx
DIffusion, Dissolution and Pharmacokinetic Parameters.pptxDIffusion, Dissolution and Pharmacokinetic Parameters.pptx
DIffusion, Dissolution and Pharmacokinetic Parameters.pptxKailas Mali
 
Objectives and policies of cGMP & Inventory management and control
Objectives and policies of cGMP & Inventory management and controlObjectives and policies of cGMP & Inventory management and control
Objectives and policies of cGMP & Inventory management and controlArul Packiadhas
 
Cmc postapproval regulatory affairs (ppt)
Cmc postapproval regulatory affairs (ppt)Cmc postapproval regulatory affairs (ppt)
Cmc postapproval regulatory affairs (ppt)suresh gautam
 
Non clinical drug development. ppt
Non clinical drug development. pptNon clinical drug development. ppt
Non clinical drug development. pptPRABU12345678
 
Requirement to clinical study process.pptx
Requirement to clinical study process.pptxRequirement to clinical study process.pptx
Requirement to clinical study process.pptxShiva Kant Thakur
 
DEVELOPING CLINICAL TRIAL PROTOCOL BY PRANAV LENDHEY.pptx
DEVELOPING CLINICAL TRIAL PROTOCOL BY PRANAV LENDHEY.pptxDEVELOPING CLINICAL TRIAL PROTOCOL BY PRANAV LENDHEY.pptx
DEVELOPING CLINICAL TRIAL PROTOCOL BY PRANAV LENDHEY.pptx36PranavLendhey
 
Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)Himal Barakoti
 
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...deepalisanap31
 
VALIDATION OF SPECIFIC DOSAGEFORMS.pptx
VALIDATION OF SPECIFIC DOSAGEFORMS.pptxVALIDATION OF SPECIFIC DOSAGEFORMS.pptx
VALIDATION OF SPECIFIC DOSAGEFORMS.pptxchinjuvineeth
 
Government regulation in pharmaceutical validation
Government regulation in pharmaceutical validationGovernment regulation in pharmaceutical validation
Government regulation in pharmaceutical validationVaishnaviRaut6
 

What's hot (20)

Six System Inspection Model.pptx
Six System Inspection Model.pptxSix System Inspection Model.pptx
Six System Inspection Model.pptx
 
ICH Q8 GUIDELINES OF QUALITY BY DESIGN(PRODUCT DEVELOPEMENT)
ICH Q8 GUIDELINES OF QUALITY BY DESIGN(PRODUCT DEVELOPEMENT)ICH Q8 GUIDELINES OF QUALITY BY DESIGN(PRODUCT DEVELOPEMENT)
ICH Q8 GUIDELINES OF QUALITY BY DESIGN(PRODUCT DEVELOPEMENT)
 
Study of consolidation parameters
Study of consolidation parametersStudy of consolidation parameters
Study of consolidation parameters
 
ICH Q8 Guidelines
ICH Q8 GuidelinesICH Q8 Guidelines
ICH Q8 Guidelines
 
Current Goods Manufacturing Practice & Industrial Management
Current Goods Manufacturing Practice & Industrial ManagementCurrent Goods Manufacturing Practice & Industrial Management
Current Goods Manufacturing Practice & Industrial Management
 
DIffusion, Dissolution and Pharmacokinetic Parameters.pptx
DIffusion, Dissolution and Pharmacokinetic Parameters.pptxDIffusion, Dissolution and Pharmacokinetic Parameters.pptx
DIffusion, Dissolution and Pharmacokinetic Parameters.pptx
 
Documentation in Pharmaceutical Industry
Documentation in Pharmaceutical IndustryDocumentation in Pharmaceutical Industry
Documentation in Pharmaceutical Industry
 
Objectives and policies of cGMP & Inventory management and control
Objectives and policies of cGMP & Inventory management and controlObjectives and policies of cGMP & Inventory management and control
Objectives and policies of cGMP & Inventory management and control
 
Preformulation
PreformulationPreformulation
Preformulation
 
Cmc postapproval regulatory affairs (ppt)
Cmc postapproval regulatory affairs (ppt)Cmc postapproval regulatory affairs (ppt)
Cmc postapproval regulatory affairs (ppt)
 
Out of specification (oos)1
Out of specification (oos)1Out of specification (oos)1
Out of specification (oos)1
 
Non clinical drug development. ppt
Non clinical drug development. pptNon clinical drug development. ppt
Non clinical drug development. ppt
 
Requirement to clinical study process.pptx
Requirement to clinical study process.pptxRequirement to clinical study process.pptx
Requirement to clinical study process.pptx
 
DEVELOPING CLINICAL TRIAL PROTOCOL BY PRANAV LENDHEY.pptx
DEVELOPING CLINICAL TRIAL PROTOCOL BY PRANAV LENDHEY.pptxDEVELOPING CLINICAL TRIAL PROTOCOL BY PRANAV LENDHEY.pptx
DEVELOPING CLINICAL TRIAL PROTOCOL BY PRANAV LENDHEY.pptx
 
Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)Investigation of medicinal product dossier (IMPD)
Investigation of medicinal product dossier (IMPD)
 
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...
DATION OF EQUIPMENT ICH AND WHO GUIDELINES FOR CALIBRATION AND VALIDATION OF ...
 
VALIDATION OF SPECIFIC DOSAGEFORMS.pptx
VALIDATION OF SPECIFIC DOSAGEFORMS.pptxVALIDATION OF SPECIFIC DOSAGEFORMS.pptx
VALIDATION OF SPECIFIC DOSAGEFORMS.pptx
 
Government regulation in pharmaceutical validation
Government regulation in pharmaceutical validationGovernment regulation in pharmaceutical validation
Government regulation in pharmaceutical validation
 
NDA & ANDA approval
NDA & ANDA approval NDA & ANDA approval
NDA & ANDA approval
 
Validation
ValidationValidation
Validation
 

Similar to Validation

validationandcalibrationmasterplan-190223191733.pptx
validationandcalibrationmasterplan-190223191733.pptxvalidationandcalibrationmasterplan-190223191733.pptx
validationandcalibrationmasterplan-190223191733.pptxTanmayPanigrahy
 
Validation Master Plan Modern Pharmaceutics
Validation Master Plan Modern PharmaceuticsValidation Master Plan Modern Pharmaceutics
Validation Master Plan Modern PharmaceuticsMittalGandhi
 
Vish- Validation Master Plan
Vish- Validation Master PlanVish- Validation Master Plan
Vish- Validation Master PlanVishal Parikh
 
Validation and calibration of master plan
Validation and calibration of master planValidation and calibration of master plan
Validation and calibration of master planPrinka Choudhary
 
Pharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical
 
validation and verification of medical device.pptx
validation and verification of medical device.pptxvalidation and verification of medical device.pptx
validation and verification of medical device.pptxGargiVaghela
 
Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation' Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation' Sanathoiba Singha
 
validationmasterplan-180918073044 (3).pdf
validationmasterplan-180918073044 (3).pdfvalidationmasterplan-180918073044 (3).pdf
validationmasterplan-180918073044 (3).pdfabdo badr
 
Validation master plan
Validation master planValidation master plan
Validation master planDr. Amsavel A
 
209422504 process-audit-check-list
209422504 process-audit-check-list209422504 process-audit-check-list
209422504 process-audit-check-listUsama Waly
 
Pharmaceutical Validation.pdf
Pharmaceutical Validation.pdfPharmaceutical Validation.pdf
Pharmaceutical Validation.pdfGireesh Kumar Eri
 
1MP from Comecer
1MP from Comecer1MP from Comecer
1MP from ComecerComecer
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validationMadhavMady3
 
Validation of pharmaceutical industries
Validation of pharmaceutical industriesValidation of pharmaceutical industries
Validation of pharmaceutical industriesPrima Ramadhani
 
Pharmaceutical validation.pptx
Pharmaceutical validation.pptxPharmaceutical validation.pptx
Pharmaceutical validation.pptxArpithaNandakumar1
 

Similar to Validation (20)

validationandcalibrationmasterplan-190223191733.pptx
validationandcalibrationmasterplan-190223191733.pptxvalidationandcalibrationmasterplan-190223191733.pptx
validationandcalibrationmasterplan-190223191733.pptx
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
ValidationMasterPlan
ValidationMasterPlanValidationMasterPlan
ValidationMasterPlan
 
Validation Master Plan Modern Pharmaceutics
Validation Master Plan Modern PharmaceuticsValidation Master Plan Modern Pharmaceutics
Validation Master Plan Modern Pharmaceutics
 
Vish- Validation Master Plan
Vish- Validation Master PlanVish- Validation Master Plan
Vish- Validation Master Plan
 
Validation and calibration of master plan
Validation and calibration of master planValidation and calibration of master plan
Validation and calibration of master plan
 
Pharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical Qualification & Validation
Pharmaceutical Qualification & Validation
 
Validation
ValidationValidation
Validation
 
validation and verification of medical device.pptx
validation and verification of medical device.pptxvalidation and verification of medical device.pptx
validation and verification of medical device.pptx
 
Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation' Notes for the subject 'Pharmaceutical Validation'
Notes for the subject 'Pharmaceutical Validation'
 
validationmasterplan-180918073044 (3).pdf
validationmasterplan-180918073044 (3).pdfvalidationmasterplan-180918073044 (3).pdf
validationmasterplan-180918073044 (3).pdf
 
Validation master plan
Validation master planValidation master plan
Validation master plan
 
209422504 process-audit-check-list
209422504 process-audit-check-list209422504 process-audit-check-list
209422504 process-audit-check-list
 
PHARMACEUTICAL VALIADATION
PHARMACEUTICAL VALIADATIONPHARMACEUTICAL VALIADATION
PHARMACEUTICAL VALIADATION
 
Pharmaceutical Validation.pdf
Pharmaceutical Validation.pdfPharmaceutical Validation.pdf
Pharmaceutical Validation.pdf
 
1MP from Comecer
1MP from Comecer1MP from Comecer
1MP from Comecer
 
QUALIFICATION OF HPTLC,HPTLC
QUALIFICATION  OF HPTLC,HPTLCQUALIFICATION  OF HPTLC,HPTLC
QUALIFICATION OF HPTLC,HPTLC
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Validation of pharmaceutical industries
Validation of pharmaceutical industriesValidation of pharmaceutical industries
Validation of pharmaceutical industries
 
Pharmaceutical validation.pptx
Pharmaceutical validation.pptxPharmaceutical validation.pptx
Pharmaceutical validation.pptx
 

More from Mehak AggarwAl

nanoparticles-and-their-medical-applications.pptx
nanoparticles-and-their-medical-applications.pptxnanoparticles-and-their-medical-applications.pptx
nanoparticles-and-their-medical-applications.pptxMehak AggarwAl
 
in-vitro-in-vivo-correlation-
in-vitro-in-vivo-correlation-in-vitro-in-vivo-correlation-
in-vitro-in-vivo-correlation-Mehak AggarwAl
 
DRUG ABSORPTION FROM GASTROINTESTINAL TRACT
DRUG ABSORPTION FROM GASTROINTESTINAL TRACTDRUG ABSORPTION FROM GASTROINTESTINAL TRACT
DRUG ABSORPTION FROM GASTROINTESTINAL TRACTMehak AggarwAl
 
role-of-dosage-form-in-gastrointestinal-absorption.pptx
role-of-dosage-form-in-gastrointestinal-absorption.pptxrole-of-dosage-form-in-gastrointestinal-absorption.pptx
role-of-dosage-form-in-gastrointestinal-absorption.pptxMehak AggarwAl
 
viral-and-non-viral-gene-transfer.pptx
viral-and-non-viral-gene-transfer.pptxviral-and-non-viral-gene-transfer.pptx
viral-and-non-viral-gene-transfer.pptxMehak AggarwAl
 
liposomal-gene-delivery-system.pptx
liposomal-gene-delivery-system.pptxliposomal-gene-delivery-system.pptx
liposomal-gene-delivery-system.pptxMehak AggarwAl
 
biopharmaceutics-of-antisense-molecule-and-aptamers.pptx
biopharmaceutics-of-antisense-molecule-and-aptamers.pptxbiopharmaceutics-of-antisense-molecule-and-aptamers.pptx
biopharmaceutics-of-antisense-molecule-and-aptamers.pptxMehak AggarwAl
 
Targeted drug delivery system
Targeted drug delivery systemTargeted drug delivery system
Targeted drug delivery systemMehak AggarwAl
 
Tumour targeting and brain specific drug delivery
Tumour targeting and brain specific drug deliveryTumour targeting and brain specific drug delivery
Tumour targeting and brain specific drug deliveryMehak AggarwAl
 
Nonclinical drug development
Nonclinical drug developmentNonclinical drug development
Nonclinical drug developmentMehak AggarwAl
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compactionMehak AggarwAl
 
Osmotic activated drug delivery system
Osmotic activated drug delivery systemOsmotic activated drug delivery system
Osmotic activated drug delivery systemMehak AggarwAl
 
Enzyme activated drug delivery systems
Enzyme activated drug delivery systemsEnzyme activated drug delivery systems
Enzyme activated drug delivery systemsMehak AggarwAl
 
P h activated drug delivery systems
P h  activated drug delivery systemsP h  activated drug delivery systems
P h activated drug delivery systemsMehak AggarwAl
 
Mechanically activated drug delivery system
Mechanically activated drug delivery systemMechanically activated drug delivery system
Mechanically activated drug delivery systemMehak AggarwAl
 
Bioelectronic medicine
Bioelectronic medicineBioelectronic medicine
Bioelectronic medicineMehak AggarwAl
 

More from Mehak AggarwAl (20)

nanoparticles-and-their-medical-applications.pptx
nanoparticles-and-their-medical-applications.pptxnanoparticles-and-their-medical-applications.pptx
nanoparticles-and-their-medical-applications.pptx
 
in-vitro-in-vivo-correlation-
in-vitro-in-vivo-correlation-in-vitro-in-vivo-correlation-
in-vitro-in-vivo-correlation-
 
DRUG ABSORPTION FROM GASTROINTESTINAL TRACT
DRUG ABSORPTION FROM GASTROINTESTINAL TRACTDRUG ABSORPTION FROM GASTROINTESTINAL TRACT
DRUG ABSORPTION FROM GASTROINTESTINAL TRACT
 
role-of-dosage-form-in-gastrointestinal-absorption.pptx
role-of-dosage-form-in-gastrointestinal-absorption.pptxrole-of-dosage-form-in-gastrointestinal-absorption.pptx
role-of-dosage-form-in-gastrointestinal-absorption.pptx
 
viral-and-non-viral-gene-transfer.pptx
viral-and-non-viral-gene-transfer.pptxviral-and-non-viral-gene-transfer.pptx
viral-and-non-viral-gene-transfer.pptx
 
liposomal-gene-delivery-system.pptx
liposomal-gene-delivery-system.pptxliposomal-gene-delivery-system.pptx
liposomal-gene-delivery-system.pptx
 
biopharmaceutics-of-antisense-molecule-and-aptamers.pptx
biopharmaceutics-of-antisense-molecule-and-aptamers.pptxbiopharmaceutics-of-antisense-molecule-and-aptamers.pptx
biopharmaceutics-of-antisense-molecule-and-aptamers.pptx
 
Targeted drug delivery system
Targeted drug delivery systemTargeted drug delivery system
Targeted drug delivery system
 
Tumour targeting and brain specific drug delivery
Tumour targeting and brain specific drug deliveryTumour targeting and brain specific drug delivery
Tumour targeting and brain specific drug delivery
 
Usfda
UsfdaUsfda
Usfda
 
Hipaa
HipaaHipaa
Hipaa
 
Nonclinical drug development
Nonclinical drug developmentNonclinical drug development
Nonclinical drug development
 
Validation part 2
Validation part 2Validation part 2
Validation part 2
 
Compression and compaction
Compression and compactionCompression and compaction
Compression and compaction
 
Osmotic activated drug delivery system
Osmotic activated drug delivery systemOsmotic activated drug delivery system
Osmotic activated drug delivery system
 
Enzyme activated drug delivery systems
Enzyme activated drug delivery systemsEnzyme activated drug delivery systems
Enzyme activated drug delivery systems
 
P h activated drug delivery systems
P h  activated drug delivery systemsP h  activated drug delivery systems
P h activated drug delivery systems
 
Mechanically activated drug delivery system
Mechanically activated drug delivery systemMechanically activated drug delivery system
Mechanically activated drug delivery system
 
Bioelectronic medicine
Bioelectronic medicineBioelectronic medicine
Bioelectronic medicine
 
Personalized medicine
Personalized medicinePersonalized medicine
Personalized medicine
 

Recently uploaded

“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxRoyAbrique
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 

Recently uploaded (20)

“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptxContemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
Contemporary philippine arts from the regions_PPT_Module_12 [Autosaved] (1).pptx
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 

Validation

  • 2. CONTENT Introduction Objectives of Validation Scope & Merits of Validation Validation Master Plan Calibration Master Plan ICH and WHO guidelines for Calibration & Validation of equipment References 4/6/2022 MEHAK AGGARWAL 2
  • 3. INTRODUCTION •As per FDA Validation, It is defined as “ establishing a Documented evidence, which provides a high degree of assurance that a specific process will consistently produce a product meeting its pre-determined specifications and quality attributes”. •As per WHO, Validation means providing documented evidence that any procedure, process, activity or system actually leads to the expected results. •According to European commission, validation is “Action providing in accordance with the principles of GMP, that any procedure, process, equipment, material, activity or system actually lead to the expected results”. 4/6/2022 MEHAK AGGARWAL 3
  • 4. OBJECTIVES •To reach risk of regulatory non-compliance. •Reduction of time to the market for the new products. •Eliminates the scrap and reduces the defect cost. •To reduce chances of product re-call from market. •The final release of product batch would be expedited. •It requires less in-process control and end process testing. •Parametric release of batch can be achieved in validation. 4/6/2022 MEHAK AGGARWAL 4
  • 5. SCOPE OF VALIDATION •Pharmaceutical validation is a vast area of work and it practically courses every aspect of pharmaceutical processing activities, hence defining scope of validation becomes a really difficult task. However, a systematic look at the pharmaceutical operations will point out at least the following areas for pharmaceutical validation: Analytical Facilities Manufacturing operations Product design Cleaning 4/6/2022 MEHAK AGGARWAL 5
  • 6. MERITS OF VALIDATION •Knowledge of the process increases during the validation process. •Consistency of the process is ensured. •It decrease the risk of the manufacturing problems. •Ensures the fluency of the production. •Decrease the expenses. •Decrease the risk of failing in GMP. 4/6/2022 MEHAK AGGARWAL 6
  • 7. VALIDATION MASTER PLAN (VMP) •A validation master plan(VMP) is a comprehensive document describing the applicable validation requirement for the facility, and providing a plan for the meeting those requirements. 4/6/2022 MEHAK AGGARWAL 7
  • 8. Scope of VMP •VMP includes all relevant expects relating to the production of pharmaceuticals in the production facility. The principle of validation, the organization of qualification and equipment are also described. •All facilities used in various production areas, storage, services and the rooms for staff. In short, it is a documented evidence that provides a high degree of Assurance that a specific process will consistently produce a product that makes its predetermined specifications and quality attributes. 4/6/2022 MEHAK AGGARWAL 8
  • 9. Why to perform VMP? •VMP is not a requirement of FDA, but it has become almost an industry standard. •It is important to include such a document, as it sets the overall goals and limits that will be followed during validation and can be referred to throughout the project. •As a reference document, the plan permits the reviewer immediately to understand the scope of the validation and avoid misconceptions. •The validation plan is thus used to set the limits of validation, to define the scope of the project, the systems included and not included in the qualification and what the project will attempt to prove. 4/6/2022 MEHAK AGGARWAL 9
  • 10. Members of VMP •Validation manager, QA department • Member from production •Member engineering •Member from calibration lab •Member from QC lab •Member from maintenance •Member from HVAC department •Member from product development lab 4/6/2022 MEHAK AGGARWAL 10
  • 11. Qualification •Qualification must be in accordance with the job requirement in combination with experience. •The resumes of validation team members are presented in a separate folder, including contract help. 4/6/2022 MEHAK AGGARWAL 11 Content of VMP 1. Introduction •Introduction to validation process and facility. •Includes- description of facility, premises, equipment, purpose, intension and scope of validation.
  • 12. 2. Methodology •It addresses pre-determined requirements by identifying standard that are to be applied to facility. •These are then used in development of the acceptance criteria that are used to judge the validation. •It involves planning, execution of documents, reports, Standards involve three elements- a) Regulatory and guidance document b) National standard c) Company standards 4/6/2022 MEHAK AGGARWAL 12
  • 13. 3. Qualification •This section encompasses all aspects of design, installation and procurement, installation and commissioning process. 4. Personnel •VMP should lay down the qualification requirements. •It must address the aspects like experience of personnel, in-house training reports etc. •Documenting the training is essential and is a requisite of the GMPs. 5. Schedule •Work program is essential and should be prepared at an early stage. A good plan will contain all necessary features which are to be considered during execution of a plan and determine control of project. •It ensures that all personnel involved in VMP are not only aware of engineering targets but also validation targets. 4/6/2022 MEHAK AGGARWAL 13
  • 14. 6. Preventive maintenance •It is responsibility of site maintenance and operation department. •This activity should be performed during the design phase and that documentation required should be, included in the requisition. 7. Procedures •These cover engineering standards used in project design, through to commissioning phases and the facilities standard procedures(SOPs). 8. Change control •Requirements for a set of procedures for change control that cover: oproject through design, construction and commissioning o ongoing change that will inevitably occur in both process, equipment and engineering aspects. 4/6/2022 MEHAK AGGARWAL 14
  • 15. 9. Documentation •Identify the documentation that should be produced for the processing like oengineering drawing oEquipment supplier drawing and documents ofactory acceptance documents oIQ document oOQ document oPQ document 10. Appendices •Appendix is mostly used VMP to hold information of type of documents and formats that will be used in execution stage. 4/6/2022 MEHAK AGGARWAL 15
  • 16. CALIBRATION MASTER PLAN CALIBRATION •To maintain accuracy and precision of test equipment at all times. •To ensure the highest level of confidence in all measurement that affect materials deposition decision with unbroken chain of traceability to national standard. •To determine whether equipment is still fit for its intended purpose. •It is based on comparison of a primary standard or instrument of known accuracy with another equipment (to be calibrated). • It is used to detect, report or eliminate by adjustment of any variation in the accuracy of equipment being calibrated. 4/6/2022 MEHAK AGGARWAL 16
  • 17. CMP •Assigning responsibilities for equipment users, equipment managers, quality assurance personnel and calibration vendors to help and Shaw company-wide consistency and regulation of your processes. •Approving calibration vendors such that they are in compliance with the guidelines of your quality system. •Identifying and labelling equipment. •Processing investigations of out of tolerance conditions and other calibration related issues that may necessitate corrective action. •Controlling and storing records, including calibration certificates, status change forms and calibration SOPs. 4/6/2022 MEHAK AGGARWAL 17
  • 18. WHY CALIBRATE? •Components age and equipment undergoes changes in temperature and humidity or sustains mechanical stress and therefore their performance degrades. This is called drift. Then test results become unreliable. While drift cannot be eliminated, it can be detected and either corrected or compensated for through the process of calibration. •Calibration: ooptimizes resources oensures consistence oensure measurements 4/6/2022 MEHAK AGGARWAL 18
  • 19. EQUIPMENT CLASSIFICATION a) Critical equipment •Direct measurement that affect the final product quality specification. b) Non-critical equipment •Indirect measurement that will not directly affect the final product quality. •Shall be maintained based on company maintenance schedule. PROCESS OF CALIBRATION •Calibration process must be managed and executed in a professional manner. A particular place for all calibration operations to take place and keeping all instruments for calibration. •Separate room is preferred because obetter environmental control obetter protection against unauthorized handling or use of calibration instruments. 4/6/2022 MEHAK AGGARWAL 19
  • 20. •Performance of all calibration operations is assigned as the clear responsibility of just one person. •Calibration procedures, used for QC function are controlled by International standard ISO 9000. It required that all persons using calibration equipment be adequately trained. VERIFICATION •Applicable to equipment that cannot be calibrated (adjustment, correlation, etc.). •Verification against measurement standard with correlation factor documented. •Actual reporting of result shall include the correlation factor- correlation factor = -2ºC measured value =24ºC reported value = 24ºC-2ºC=22ºC 4/6/2022 MEHAK AGGARWAL 20
  • 21. CALIBRATION RECORDS CMP include the control of all critical measurement equipment that contain the following detail. •Name •Identification by model number and serial number •Location •Owner/responsible •Calibration frequency •Calibration due date •Calibration certificate •Calibration procedure 4/6/2022 MEHAK AGGARWAL 21
  • 22. CALIBRATION CERTIFICATE •Name and address of contracted calibration laboratory. •Name and address of client. •Description and identification of item calibrated. •Environment conditions when calibration was made. •Date of receipt of instrument, date of calibration and date of next calibration. •Calibration method. •Result of calibration. •Signature and title of person responsible for the calibration. •External calibration contract shall be awarded to accredited by Nation Institution. 4/6/2022 MEHAK AGGARWAL 22
  • 23. ICH AND WHO GUIDELINES FOR CALIBRATION & VALIDATION OF EQUIPMENT ICH GUIDELINES FOR CALIBRATION OF EQUIPMENT •Local identification by a unique identification number and involvement in master GMP instrument list •Procedure for instrument history file. •Approval by quality unit. •Generation of procedure for verification and standardization of accuracy and reliability. •For approval of procedure, it must contain steps and forms required for calibration. •Involvement of calibration stickers and auxiliary stickers program. •Procedure for tracking of Scheduled calibration activities. •Procedure for notifying users of calibration due dates, overdue calibrations and out of tolerance findings. 4/6/2022 MEHAK AGGARWAL 23
  • 24. •Review of all systems, calibration records and procedure by quality unit. •Involvement of procedure for reporting any GMP critical instrument. •Involvement of calibration forms which are developed to record the calibration results. WHO GUIDELINES FOR CALIBRATION OF EQUIPMENT •Regular calibration. •Establishment of specific procedure of calibration for every equipment. •Only authorized personnel should operate equipment. •Availability of up-to-date instructions for calibration verification results must be recorded on a control chart. •Unique identification of each item of equipment for calibration. •Keeping of records of each item of equipment to perform calibration. •Systematic verification of laboratory to prevent contamination. •Establishment of maintenance procedure. 4/6/2022 MEHAK AGGARWAL 24
  • 25. •Out of service equipment. •Labelling of equipment. •Verification of equipment function and calibration status. EXAMPLE FOR CALIBRATION OF UV SPECTROPHOTOMETER 1. Control of wavelength • Verify wavelength scale using absorption maxima of holmium per chlorate solution with the line of hydrogen or deuterium discharge lamp or lines of mercury vapor arc. •The permitted tolerance is +/-1 nm for the range 200 to 400nm. 2. Control of absorbance •Check the absorbance using potassium dichromate solution UV at different wavelengths. 4/6/2022 MEHAK AGGARWAL 25
  • 26. 3. Limit of stray light •Detected at a given wavelength with suitable filters or solutions; for ex. potassium chloride. 4. Resolution power •Record the spectrum of a 0.02% v/v solution of toluene in hexane UV. Ratio of the absorbance is NLT 1.5 . 5. Spectral slit width •Spectral slit width must be small compared with the half- width of the absorption band. 4/6/2022 MEHAK AGGARWAL 26
  • 27. ICH GUIDELINES FOR VALIDATION OF EQUIPMENT •1 meter distance from walls and other obstacles. •Easy to operate, clean and maintainable. •Working should be at proper commissioned position. •Certification of equipment. •Checking of overhead heights. •Proper source of light. •Drop down utility system. •Design of equipment. •Layout of equipment. •Marking of pipelines as per their flow of direction. 4/6/2022 MEHAK AGGARWAL 27
  • 28. •Sop the equipment. •Tracing of equipment. •Identification marking for equipment. •Cleaning of equipment. •Distinguishing of the equipment. •Record of each processing. WHO GUIDELINES FOR VALIDATION OF EQUIPMENT •Equipment must be located, designed, constructed, adapted and maintained to suit the operation. •Layout and design of equipment. •Instalment of equipment. •Production equipment. 4/6/2022 MEHAK AGGARWAL 28
  • 29. •Labelling of fixed pipe work. •Cleaning of equipment. •Labelling of equipment. •Establishment of written procedures for each operation. •Record keeping. EXAMPLE OF VALIDATION OF TABLET COMPRESSION MACHINE 1. Execution of Design 2. Qualification Execution of IQ, OQ and PQ 3. Procedure Followed for Performance Qualification •The blend/dummy material was unloaded into the hoppers on the both sides and the compression machine was operated at low speed (20RPM) as per operating instructions. Then the machine was set to run for 20 minutes continuously after adjusting the following parameters- 4/6/2022 MEHAK AGGARWAL 29
  • 30. oIndividual tablet weight variation oWeight of 20 tablets oHardness oThickness oDisintegration time oFriability •Repeat the procedure at both medium (40RPM) and high speed (60RPM) with same set of parameters. •Checking of parameters at different speeds. •Report the results. •Sampling Plan 1. Collect 100 tablets for every 05 minutes. 2. Compression parameters checked at different speeds. •Optimum results obtained at 40 rpm speed. 4/6/2022 MEHAK AGGARWAL 30
  • 31. REFERENCES •Potdar MA, “cGMP, current good manufacturing practises for pharmaceuticals”, 2nd reprint, Pharmamed press, Hyderabad, p. 85,88-101,413-423. •Joseph Busfield. cGMP, instrument and calibration. “Facilities, utilities and requirements, GXP, Ivt network”. Feb 21,2007;5-7. Available from: https://www.ivtnetwork.com/article/cgmp-equipment- instruments-and-calibration •Guidelines : ICH. “ICH harmonization for better health”. Available from: https://www.ich.org/page/ich-guidelines •Essential medicines and health products information portal. “WHO expert committee on specifications for pharmaceutical preparations”. World Health Organization.Technical report series no. 902-36th report.2002. 4/6/2022 MEHAK AGGARWAL 31